Clinical Trials Directory

Trials / Completed

CompletedNCT01483755

Delayed Postconditioning

Delayed Angioplasty Postconditioning in STEMI Patients

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators previously reported that angioplasty postconditioning reduces infarct size (cardiac enzyme release) in STEMI patients with a fully occluded coronary artery at hospital admission. Animal studies have suggested that the time window for applying brief episodes of ischemia and reperfusion aimed at triggering postconditioning's protection is very narrow, i.e. does not expand beyond 1 minute after reflow. We sought to address whether this window might be larger in humans, i.e. whether STEMI patients might be protected several minutes after undergoing spontaneous reperfusion before admission coronary angiography. Therefore, STEMI patients (onset of chest pain less than 12 hours) with a TIMI flow grade \> 1 were eligible for that study. Angioplasty postconditioning was completed as already published and infarct size was assessed by measuring cardiac enzymes release.

Conditions

Interventions

TypeNameDescription
PROCEDUREPostconditioningPostconditioning consists of four cycles of one minute balloon inflation followed by one minute of balloon deflation, with the initial inflation being started within the first minute after reopening of the culprit coronary artery.
PROCEDUREPercutaneaous interventionConventional primary percutaneaous intervention

Timeline

Start date
2009-07-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2011-12-01
Last updated
2025-12-19

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01483755. Inclusion in this directory is not an endorsement.